Amidate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Etomidate.
| Product ID | 0409-6695_41253af6-deac-43de-9af3-3b727ea351d8 |
| NDC | 0409-6695 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Amidate |
| Generic Name | Etomidate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2005-07-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018227 |
| Labeler Name | Hospira, Inc. |
| Substance Name | ETOMIDATE |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2005-07-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-08-04 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-02-10 |
| Marketing End Date | 2018-08-01 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-28 |
| Marketing End Date | 2018-08-01 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-08-04 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-07-26 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-09-08 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-28 |
| Marketing End Date | 2018-02-01 |
| Marketing Category | NDA |
| Application Number | NDA018227 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-01-28 |
| Marketing End Date | 2018-08-01 |
| Ingredient | Strength |
|---|---|
| ETOMIDATE | 2 mg/mL |
| SPL SET ID: | b7ed5bf8-ba75-44dc-8f81-96b4ad5766be |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9811 | Amidate | Etomidate |
| 0409-6695 | Amidate | ETOMIDATE |
| 0409-8060 | Amidate | Etomidate |
| 52584-695 | Amidate | Etomidate |
| 0143-9310 | Etomidate | Etomidate |
| 0143-9311 | Etomidate | Etomidate |
| 0143-9506 | Etomidate | Etomidate |
| 0143-9507 | Etomidate | Etomidate |
| 23155-160 | Etomidate | Etomidate |
| 23155-522 | Etomidate | Etomidate |
| 25021-674 | etomidate | etomidate |
| 51662-1485 | ETOMIDATE | ETOMIDATE |
| 51662-1542 | ETOMIDATE | ETOMIDATE |
| 55150-221 | ETOMIDATE | ETOMIDATE |
| 55150-222 | ETOMIDATE | ETOMIDATE |
| 65145-127 | Etomidate | Etomidate |
| 65145-128 | Etomidate | Etomidate |
| 65219-445 | Etomidate | Etomidate |
| 65219-447 | Etomidate | Etomidate |
| 65841-818 | etomidate | etomidate |
| 67457-902 | Etomidate | Etomidate |
| 67457-903 | Etomidate | Etomidate |
| 68382-545 | etomidate | etomidate |
| 70518-1003 | Etomidate | etomidate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMIDATE 77668975 3663648 Live/Registered |
Hospira, Inc. 2009-02-12 |
![]() AMIDATE 73119674 1078739 Dead/Expired |
ABBOTT LABORATORIES 1977-03-21 |